Belgium vs Poland: HIV/AIDS deaths averted by antiretroviral therapy
Belgium
636.61 deaths
in 2024
Poland
683 deaths
in 2021
Belgium rank
85th
Poland rank
84th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Belgium
- Poland
How they compare
Poland currently reports 683 deaths against 636.61 deaths in Belgium, a difference of 46.39 deaths.
That makes Poland's figure about 1.1 times Belgium's.
The two have swapped places 4 times across 32 shared years of data; in 1990 it was Poland ahead.
Belgium ranks 85th and Poland ranks 84th of 157 countries.
Belgium has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Belgium | Poland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 99.54 deaths | 40.1 deaths | 59.44 deaths | Belgium |
| 2000s | 355.19 deaths | 326.9 deaths | 28.29 deaths | Belgium |
| 2010s | 595.22 deaths | 512.7 deaths | 82.52 deaths | Belgium |
| 2020s | 662.71 deaths | 662 deaths | 0.7105 deaths | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Belgium or Poland?
- Poland, at 683 deaths against 636.61 deaths in Belgium as of 2021.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Belgium and Poland?
- 46.39 deaths, with Poland ahead.
- How many years of comparable data are there for Belgium and Poland?
- 32 years are reported by both, from 1990 to 2021.
- How do Belgium and Poland rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Belgium ranks 85th and Poland ranks 84th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.